Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · IEX Real-Time Price · USD
12.07
+0.11 (0.92%)
At close: May 17, 2024, 4:00 PM
11.75
-0.32 (-2.65%)
After-hours: May 17, 2024, 4:06 PM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ZNTL stock have an average target of 42.14, with a low estimate of 15 and a high estimate of 70. The average target predicts an increase of 249.13% from the current stock price of 12.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ZNTL stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $40 | Strong Buy | Maintains | $46 → $40 | +231.40% | May 8, 2024 |
| Stifel | Stifel | Strong Buy Maintains $36 → $32 | Strong Buy | Maintains | $36 → $32 | +165.12% | May 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +281.11% | Feb 28, 2024 |
| Wedbush | Wedbush | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +24.28% | Feb 28, 2024 |
| Wedbush | Wedbush | Buy → Hold Downgrades $38 → $12 | Buy → Hold | Downgrades | $38 → $12 | -0.58% | Nov 8, 2023 |
Financial Forecast
Revenue This Year
11.90M
Revenue Next Year
4.92M
from 11.90M
Decreased by -58.69%
EPS This Year
-3.74
from -4.47
EPS Next Year
-3.85
from -3.74
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.8M | 40.5M | 363.0M | 458.2M | 771.3M |
| Avg | 11.9M | 4.9M | 68.0M | 169.6M | 379.6M |
| Low | n/a | n/a | n/a | 54.9M | 154.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 240.2% | 7,283.6% | 573.5% | 354.9% |
| Avg | - | -58.7% | 1,283.8% | 149.3% | 123.8% |
| Low | - | - | - | -19.3% | -9.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.17 | -3.19 | -0.43 | -1.25 | 0.87 |
| Avg | -3.74 | -3.85 | -3.21 | -2.29 | -0.53 |
| Low | -3.98 | -4.36 | -4.56 | -2.96 | -2.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.